← Human Trials & Peer-Reviewed Studies
Modulatory effect of two regimens of magnesium sulfate on the systemic inflammatory response in pregnant women with imminent eclampsia.
Plain-language guide to PMID 35728369 (2022): single-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 33 women.
Key Facts
- PMID
- 35728369
- Journal
- Pregnancy hypertension
- Year
- 2022
- Study type
- Randomized Controlled Trial
- Authors
- Peraçoli JC et al. (9 authors)
- DOI
- 10.1016/j.preghy.2022.06.002
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial looks at Vitamin D, K2, Magnesium and Zinc.
This study compared the modulatory effect of two intravenous magnesium sulfate (MgSO4) regimens on the systemic inflammatory response in pregnant women diagnosed with imminent eclampsia.
Plasma was used to determine interleukin (IL)-1 beta (IL-1β), IL-6, IL-10, tumor necrosis factor-alpha (TNF-α), heat shock protein (Hsp70), and heme oxygenase-1 (HO-1) by ELISA.
Who Took Part
According to the abstract, 33 women were involved.
PubMed tags the participants as women only.
In a single-blind cross-sectional study, 33 women were allocated according to the Zuspan (n = 16) and Sibai (n = 17) MgSO4 regimens, and treated for 24 h.
How the Study Was Run
In design terms this was a randomized and single-blind study.
Random assignment meant chance, not the researchers, decided who got Vitamin D, K2, Magnesium and Zinc and who got the comparison, which limits bias.
Only one side, usually the women, was kept unaware of whether Vitamin D, K2, Magnesium and Zinc was given.
What Was Measured
PubMed files the paper under topics including Cross-Sectional Studies, Eclampsia, Interleukin-10, Interleukin-6, Magnesium Sulfate, Pre-Eclampsia and Pregnant People.
The authors tagged it with the keywords Cytokines, Heme oxygenase-1, Hsp70 and Preeclampsia.
What This Means in Plain Language
The paper is a randomized and single-blind study of Vitamin D, K2, Magnesium and Zinc in 33 women.
With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.
The abstract goes on to report its results in about 4 sentences; this page does not restate them, so read the paper for the findings and their limits.
The publication is from 2022 (Pregnancy hypertension), a journal based in Netherlands.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.